These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2209118)

  • 1. Gemfibrozil interaction with warfarin sodium (coumadin).
    Ahmad S
    Chest; 1990 Oct; 98(4):1041-2. PubMed ID: 2209118
    [No Abstract]   [Full Text] [Related]  

  • 2. Gemfibrozil-warfarin drug interaction resulting in profound hypoprothrombinemia.
    Rindone JP; Keng HC
    Chest; 1998 Aug; 114(2):641-2. PubMed ID: 9726762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between gemfibrozil and warfarin: case report and review of the literature.
    Dixon DL; Williams VG
    Pharmacotherapy; 2009 Jun; 29(6):744-8. PubMed ID: 19476425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin therapy.
    Ahmad S
    Mayo Clin Proc; 1995 May; 70(5):505; author reply 505-6. PubMed ID: 7731265
    [No Abstract]   [Full Text] [Related]  

  • 5. Gemfibrozil: interaction with glyburide.
    Ahmad S
    South Med J; 1991 Jan; 84(1):102. PubMed ID: 1898783
    [No Abstract]   [Full Text] [Related]  

  • 6. Ask the doctors. There is a long list of drugs and substances that interact with Coumadin (warfarin). Does this mean they make Coumadin more effective, or less effective?
    Lee TH; Lee RT
    Harv Heart Lett; 2013 Sep; 24(1):2. PubMed ID: 24386674
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential drug-drug interaction between interferon alfa-2b and gemfibrozil in a patient with malignant melanoma.
    Wong SF; Jakowatz JG; Taheri R
    Clin Ther; 2005 Dec; 27(12):1942-8. PubMed ID: 16507380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium.
    Anthony M; Romero K; Malone DC; Hines LE; Higgins L; Woosley RL
    Clin Pharmacol Ther; 2009 Oct; 86(4):425-9. PubMed ID: 19587643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin interaction with sodium warfarin: a potentially dangerous side effect.
    Renzi R; Finkbeiner S
    Am J Emerg Med; 1991 Nov; 9(6):551-2. PubMed ID: 1930395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy.
    Pierce LR; Wysowski DK; Gross TP
    JAMA; 1990 Jul; 264(1):71-5. PubMed ID: 2355431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide.
    Niemi M; Backman JT; Neuvonen M; Neuvonen PJ
    Diabetologia; 2003 Mar; 46(3):347-51. PubMed ID: 12687332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].
    Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L
    Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in tiagabine serum concentration with coadministration of gemfibrozil.
    Burstein AH; Boudreau EA; Theodore WH
    Ann Pharmacother; 2009 Feb; 43(2):379-82. PubMed ID: 19193595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhabdomyolysis associated with gemfibrozil-colchicine therapy.
    Atmaca H; Sayarlioglu H; Külah E; Demircan N; Akpolat T
    Ann Pharmacother; 2002 Nov; 36(11):1719-21. PubMed ID: 12398566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of racemic warfarin in healthy subjects.
    Lilja JJ; Backman JT; Neuvonen PJ
    Br J Clin Pharmacol; 2005 Apr; 59(4):433-9. PubMed ID: 15801938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case with severe rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy--a case report.
    Ozdemir O; Boran M; Gökçe V; Uzun Y; Koçak B; Korkmaz S
    Angiology; 2000 Aug; 51(8):695-7. PubMed ID: 10959522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerivastatin and gemfibrozil-associated rhabdomyolysis.
    Bruno-Joyce J; Dugas JM; MacCausland OE
    Ann Pharmacother; 2001 Sep; 35(9):1016-9. PubMed ID: 11573847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of drug interactions utilizing a computerized drug prescription handling system-focus on cerivastatin-gemfibrozil.
    Morera T; Gervasini G; Carrillo JA; Benitez J
    Eur J Clin Pharmacol; 2004 Feb; 59(12):917-21. PubMed ID: 14735257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a hydroxyapatite ceramic matrix for the continuous delivery of coumadin.
    Mileti IF; Bajpai PK
    Biomed Sci Instrum; 1995; 31():177-82. PubMed ID: 7654958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemfibrozil markedly increases the plasma concentrations of montelukast: a previously unrecognized role for CYP2C8 in the metabolism of montelukast.
    Karonen T; Filppula A; Laitila J; Niemi M; Neuvonen PJ; Backman JT
    Clin Pharmacol Ther; 2010 Aug; 88(2):223-30. PubMed ID: 20592724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.